Brijnath, BiancaMuoio, RachelFeldman, PeterGhersi, DavinaChan, An-WenWelch, VivianTreweek, ShaunGreen, HeidiOrkin, Aaron MOwusu-Addo, Ebenezer2024-07-162024-07-162024-06-01Brijnath, B, Muoio, R, Feldman, P, Ghersi, D, Chan, A-W, Welch, V, Treweek, S, Green, H, Orkin, A M & Owusu-Addo, E 2024, '"We are not invited" : Australian focus group results on how to improve ethnic diversity in trials.', Journal of Clinical Epidemiology, vol. 170, 111366. https://doi.org/10.1016/j.jclinepi.2024.1113660895-4356ORCID: /0000-0002-7239-7241/work/186968600https://hdl.handle.net/2164/23816We thank The RECONSIDER Extension Group for their advice and feedback on this manuscript. The group members are: • Hayat Ahmed, MSc, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard University (MRCT Centre), Cambridge, US; • Nita Bhandari, PhD, Centre for Health Research and Development, Society for Applied Studies, New Delhi, India; • Barbara E. Bierer, MD, MRCT Centre, Harvard Medical School, Cambridge, US; • Owen Chinembiri, MA, Macmillan Cancer Support, London, UK; • Kenzie A. Cameron, PhD, MPH, Departments of Medicine, Medical Education, Medical Social Sciences and Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, US; • Daniel Coase, MA, Federation of Ethnic Communities Councils of Australia, Canberra, Australia; • Maria Cuervas, MPH, Public contributor, Santiago, Chile; • Shoba Dawson, PhD, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK; • Robert M. Golub, MD, Department of Medicine and Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, US; • Farrokh Habibzadeh, MD, Global Virus Network, Shiraz, Iran; • Merilyn Heuschkel, MPH, Strategic Research Initiatives, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia; • Lindsey Jasicki, Clinical Trials Program Manager, Cancer Institute New South Wales, Sydney, Australia; • Lillian Leigh, LLM, Public contributor, Sydney, Australia; • Tianjing Li, PhD, University of Colorado, Aurora, US; • Lawrence Mbuagbaw, PhD, Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada; • Raylynn Benn, BSc, Migrant and Refugee Health Partnership, The Social Policy Group, Canberra, Australia; • John Norrie, MSc, Edinburgh Clinical Trials Unit, The University of Edinburgh, Edinburgh, Scotland; • Mayra Ouriques, MIPH, Cancer Institute New South Wales, Sydney, Australia; • George Papadopolous, MBBS (Hons), Public contributor, Melbourne, Australia; • Dawn Richards, PhD, Patient and Public Engagement, Clinical Trials Ontario, Toronto, Canada; • Nandi Siegfried, DPhil, South African Medical Research Council, Cape Town, South Africa; • Nicola Straiton, PhD, Nursing Research Institute, St Vincent's Health Network Sydney and Australian Catholic University, Sydney, Australia; • Jvan Yazdani, PhD, Public contributor, Aberdeen, Scotland; • John Zalcberg, PhD, Department of Medical Oncology, Alfred Health, Cancer Research Program, School of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Non-executive Board Director, Australian Clinical Trials Alliance.10262681engEthnic diversityTrialsInclusionFocus groupsRecruitmentCross-culturalR MedicineSupplementary Datahttps://ars.els-cdn.com/content/image/1-s2.0-S0895435624001215-mmc1.docxhttps://ars.els-cdn.com/content/image/1-s2.0-S0895435624001215-mmc2.docxhttps://ars.els-cdn.com/content/image/1-s2.0-S0895435624001215-mmc3.pdfRJournal article10.1016/j.jclinepi.2024.111366170